Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Jan 12, 2018 8:00 am EST

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

Nov 27, 2017 11:02 am EST

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy

Nov 8, 2017 4:05 pm EST

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

Nov 7, 2017 8:00 am EST

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform

Nov 3, 2017 9:43 am EDT

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017

Oct 26, 2017 10:19 am EDT

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy

Oct 12, 2017 8:00 am EDT

OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan

Sep 19, 2017 8:00 am EDT

OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care

Sep 12, 2017 8:30 am EDT

OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings

Aug 31, 2017 8:30 am EDT

OPKO Health to Present at Upcoming September Conferences